when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Undisclosed · news · pharmadog

← back to Undisclosed

News mentioning Undisclosed

68 stories

Aug 17, 26J&J hands lymphoma bispecific CAR T back to AbelZetabiospace

Aug 17, 26Lilly pens $370M deal with OmniAb for ion channel collab, but details remain vaguefiercebiotech

Aug 14, 26After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted?fiercebiotech

Aug 13, 26Zealand sells milestone, royalty rights to rare blood cancer asset for up to $100Mbiospace

Aug 12, 26Sentynl bets up to $475M in licensing deal for Mereo’s rare lung disease assetbiospace

Aug 11, 26Ex-Legend CEO takes helm at biotech startup scouring the globe for drugsbiopharma dive

Aug 11, 26After billions in deals, Insilico CEO promises: ‘You haven't seen anything yet’biospace

Aug 11, 26Epicrispr, Infinimmune snag combined $165M in VC cashbiospace

Aug 11, 26Zydus’ Sentynl pens $475M deal for Mereo’s phase 3-ready rare genetic lung disease drugfiercebiotech

Aug 10, 26AstraZeneca partners with CSPC to build Chinese biologics manufacturing plantbiospace

Aug 10, 26Jazz pays $820M to buy Actio, adding clinical-stage asset to orchestra of epilepsy therapiesfiercebiotech

Aug 5, 26STAT+: Exemption of rare disease therapies in drug-pricing pilots would wipe out huge savings, analysis findsstat

Aug 5, 265 NextGen winners who went public this year (and which ones are hiring)biospace

Aug 4, 26Sanofi-backed Expedition uses $115M series B to advance COPD drug on phase 2 journeyfiercebiotech

Jul 28, 26Boston Scientific unveils major restructuring, plots job cuts amid savings drivefiercebiotech

Jul 20, 26FDA’s radical transparency policy for rejections runs into legal uncertaintybiospace

Jul 17, 26This Week at FDA: FDA staff raise concerns about peptide conflicts, top Democrat wants DOGE investigation, and moreraps

Jul 2, 26A PureTech startup banks $180M for a new IPF drugbiopharma dive

Jun 26, 26FDA accepts Replimune filing; Merck KGaA drops $11B on life sciences servicesbiopharma dive

Jun 18, 26Biogen adds more immune drugs in $1B buyout of secretive startup RayTherabiopharma dive

Jun 18, 26Biogen makes up to $1B deal for secretive anti-inflammatory biotechendpoints

Jun 4, 26HHS confirms Americans with high-risk Ebola exposures will have access to experimental therapystat

Jun 3, 26Lilly, Ascidian link up in RNA exon editing pactbiopharma dive

May 28, 26STAT+: As Ebola outbreak in Central Africa grows, the U.S. turns itself into a fortressstat

May 7, 26STAT+: FDA revisits a rare cancer treatment it rejected a few months agostat

May 6, 26STAT+: Administration report on most favored nation drug pricing raises new details — and questionsstat

May 1, 26STAT+: Pharmalittle: We’re reading about obesity drugs and a compounding list, an AstraZeneca setback, and morestat

Apr 30, 26STAT+: Pharmalittle: We’re reading about a Supreme Court hearing on ‘skinny labels,’ AstraZeneca U.K. expansion, and morestat

Apr 29, 26STAT+: Supreme Court justices appear to signal ‘skinny labeling’ can survivestat

Apr 29, 26FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotechbiopharma dive

← prevpage 2 of 3next →